Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Disease Progression × Tamoxifen × 1 year × Clear all

Sponsor

Conditions

Breast Neoplasms 53 Carcinoma, Intraductal, Noninfiltrating 7 Breast Carcinoma In Situ 5 Neoplasms 3 Pancreatic Neoplasms 2 Ovarian Neoplasms 2 Neoplasm Metastasis 2 Breast Neoplasms, Male 2 Triple Negative Breast Neoplasms 1 Recurrence 1 Prostatic Neoplasms 1 Precancerous Conditions 1 Multiple Endocrine Neoplasia Type 1 1 Inflammatory Breast Neoplasms 1 Infertility 1 Hyperglycemia 1 Glioblastoma 1 Endometrial Neoplasms 1 Endometrial Hyperplasia 1 ERα+ Breast Cancer 1 Carcinoma, Lobular 1 Breast Cancer Subjects 1 Breast Cancer Metastatic 1 Breast Cancer Female 1 Anatomic Stage III Breast Cancer AJCC v8 1

Interventions

Cisplatin 3 capivasertib 2 Radiosurgery 2 Nivolumab 2 Carboplatin 2 tivozanib 1 pazopanib 1 niraparib 1 lutetium Lu 177 dotatate 1 fludarabine phosphate 1 fludarabine 1 encorafenib 1 durvalumab 1 copanlisib 1 cemiplimab 1 axicabtagene ciloleucel 1 avasopasem manganese 1 abexinostat 1 Receptors, Interleukin-6 1 Radiotherapy, Intensity-Modulated 1 Radiotherapy, Image-Guided 1 Radiotherapy 1 Pemetrexed 1 Paclitaxel 1 Oxaliplatin 1 Leucovorin 1 Interleukin 1 Receptor Antagonist Protein 1 Gemcitabine 1 Fulvestrant 1 Folfox protocol 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡